XenoGesis Limited
Major Drugs - Nottingham, ENG, UK
XenoGesis Limited Employees
XenoGesis Limited Senior Management
XenoGesis Limited Details
When identifying problems is not enough....XenoGesis is a laboratory-based contract research organisation (CRO) specialised in preclinical drug metabolism & pharmacokinetics (DMPK), quantitative bioanalysis and expert interpretation. The core XenoGesis team has an enviable track record of delivery in drug discovery.It is clear that identifying poor compounds early through scientific rigor is key in preventing progression into more expensive pre-clinical tests. Even a minor improvement in early-stage drug failure prediction will result in significant time and cost savings for R&D companies. Specifically, XenoGesis can identify the potential ‘winners' and ‘losers' in a selection of compounds synthesised in drug discovery campaigns. Moreover, providing iterative feedback to the research team based on the results and recommending next steps is a key focus for XenoGesis.We combine our state-of-the-art in vitro, in vivo and bioanalytical capabilities with our expert pharmacokinetic/pharmacodynamic (PK/PD) data interpretation services.Using this integrated approach we provide you with the information required to successfully achieve your drug discovery goals.XenoGesis was acquired by Sygnature Discovery in September 2020.
XenoGesis Limited Technologies
Captcha
reCAPTCHA
Email Providers
Mimecast
Marketing Automation
Hubspot
Other
Microsoft Office 365
Hosting
Amazon AWS
Analytics and Tracking
Google Analytics